Literature DB >> 15191958

Tackling the next influenza pandemic.

Ran D Balicer, Michael Huerta, Itamar Grotto.   

Abstract

Mesh:

Substances:

Year:  2004        PMID: 15191958      PMCID: PMC421767          DOI: 10.1136/bmj.328.7453.1391

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  10 in total

Review 1.  Prevention and treatment of influenza.

Authors:  R B Couch
Journal:  N Engl J Med       Date:  2000-12-14       Impact factor: 91.245

2.  Virology. The origin and control of pandemic influenza.

Authors:  G Laver; E Garman
Journal:  Science       Date:  2001-09-07       Impact factor: 47.728

3.  The global agenda on influenza surveillance and control.

Authors:  Klaus Stöhr
Journal:  Vaccine       Date:  2003-05-01       Impact factor: 3.641

Review 4.  Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials.

Authors:  Nicola J Cooper; Alexander J Sutton; Keith R Abrams; Allan Wailoo; David Turner; Karl G Nicholson
Journal:  BMJ       Date:  2003-06-07

5.  Preventing and treating influenza.

Authors:  Klaus Stöhr
Journal:  BMJ       Date:  2003-06-07

6.  Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.

Authors:  F G Hayden; L V Gubareva; A S Monto; T C Klein; M J Elliot; J M Hammond; S J Sharp; M J Ossi
Journal:  N Engl J Med       Date:  2000-11-02       Impact factor: 91.245

7.  Oral oseltamivir treatment of influenza in children.

Authors:  R J Whitley; F G Hayden; K S Reisinger; N Young; R Dutkowski; D Ipe; R G Mills; P Ward
Journal:  Pediatr Infect Dis J       Date:  2001-02       Impact factor: 2.129

8.  Effectiveness of oseltamivir in preventing influenza in household contacts: a randomized controlled trial.

Authors:  R Welliver; A S Monto; O Carewicz; E Schatteman; M Hassman; J Hedrick; H C Jackson; L Huson; P Ward; J S Oxford
Journal:  JAMA       Date:  2001-02-14       Impact factor: 56.272

Review 9.  The economic impact of pandemic influenza in the United States: priorities for intervention.

Authors:  M I Meltzer; N J Cox; K Fukuda
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

10.  Pandemic influenza and healthcare demand in the Netherlands: scenario analysis.

Authors:  Marianne L L van Genugten; Marie-Louise A Heijnen; Johannes C Jager
Journal:  Emerg Infect Dis       Date:  2003-05       Impact factor: 6.883

  10 in total
  6 in total

1.  Prisons show prophylaxis for close contacts may indeed help in next flu pandemic.

Authors:  Niyi Awofeso
Journal:  BMJ       Date:  2004-07-17

2.  Potential impact of antiviral drug use during influenza pandemic.

Authors:  Raymond Gani; Helen Hughes; Douglas Fleming; Thomas Griffin; Jolyon Medlock; Steve Leach
Journal:  Emerg Infect Dis       Date:  2005-09       Impact factor: 6.883

Review 3.  A systematic analytic approach to pandemic influenza preparedness planning.

Authors:  Daniel J Barnett; Ran D Balicer; Daniel R Lucey; George S Everly; Saad B Omer; Mark C Steinhoff; Itamar Grotto
Journal:  PLoS Med       Date:  2005-11-01       Impact factor: 11.069

4.  Pandemic influenza preparedness: the critical role of the syringe.

Authors:  Kenneth Strauss; André van Zundert; Anders Frid; Vincenzo Costigliola
Journal:  Vaccine       Date:  2006-03-20       Impact factor: 3.641

5.  Cost-benefit of stockpiling drugs for influenza pandemic.

Authors:  Ran D Balicer; Michael Huerta; Nadav Davidovitch; Itamar Grotto
Journal:  Emerg Infect Dis       Date:  2005-08       Impact factor: 6.883

6.  Rapid molecular detection of the H275Y oseltamivir resistance gene mutation in circulating influenza A (H1N1) viruses.

Authors:  Michael J Carr; Naomi Sayre; Margaret Duffy; Jeff Connell; William W Hall
Journal:  J Virol Methods       Date:  2008-09-03       Impact factor: 2.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.